CPT® Code 86972

Pretreatment of RBCs for use in RBC antibody detection, identification, and/or compatibility testing; by density gradient separation

The CPT® Code 86972 refers to the pretreatment of red blood cells (RBCs) specifically for the purposes of detecting, identifying, and/or performing compatibility testing for RBC antibodies. This procedure utilizes a method known as density gradient separation, which is a laboratory technique that separates components of blood based on their density. In the context of this code, the process begins after a blood sample has tested positive for an antibody related to a drug. The red blood cells are then incubated with the suspected drug, and the reaction is analyzed to ascertain the presence of the drug in the bloodstream. This testing is crucial for ensuring safe and effective transfusions, as it helps identify any potential adverse reactions that may occur due to drug-antibody interactions. It is important to note that if the sample undergoes enzyme treatment prior to examination, a different code, 86971, should be used. The distinction between these codes is essential for accurate medical coding and billing, as it reflects the specific methodologies employed in the testing process.